Skip to main content
. 2012 May;53(5):979–983. doi: 10.1194/jlr.P023994

Fig. 1.

Fig. 1.

Mean PCSK9 levels in the three groups of untreated participants. The groups were categorized based on genetic FH mutation status and LDL-cholesterol level: the group where mutation was absent (control) and for FH heterozygotes, the untreated LDL-cholesterol percentile, either below the 75th percentile (FH low) or above the 90th percentile (FH high) for age and gender. Data were based on a model adjusted for age, sex, body mass index, and systolic blood pressure.